We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

113 hedge funds and large institutions have $264M invested in Surgalign Holdings, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 31 increasing their positions, 35 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

60% more capital invested

Capital invested by funds: $165M → $264M (+$99M)

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

4% more funds holding

Funds holding: 109113 (+4)

11% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 35

Holders
113
Holders Change
+4
Holders Change %
+3.67%
% of All Funds
2.45%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.09%
New
22
Increased
31
Reduced
35
Closed
18
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
+$1K
Name Holding Trade Value Shares
Change
Change in
Stake
VOYA Investment Management
76
VOYA Investment Management
Georgia
$167K
Mackenzie Financial
77
Mackenzie Financial
Ontario, Canada
$149K +$119K +824 New
MLICM
78
Metropolitan Life Insurance Company (MetLife)
New York
$129K -$1.74K -12 -2%
PPCM
79
Pillar Pacific Capital Management
California
$129K -$4.92K -34 -5%
CWM
80
Circle Wealth Management
New Jersey
$120K
Squarepoint
81
Squarepoint
New York
$116K +$93K +643 New
SG Americas Securities
82
SG Americas Securities
New York
$115K +$92.2K +637 New
Prudential Financial
83
Prudential Financial
New Jersey
$99K +$79.7K +551 New
JP Morgan Chase
84
JP Morgan Chase
New York
$95K -$60.2K -416 -44%
Connor, Clark & Lunn Investment Management (CC&L)
85
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$95K -$2.17K -15 -3%
ZCM
86
Zebra Capital Management
Connecticut
$94K +$11.4K +79 +18%
CS
87
Credit Suisse
Switzerland
$93K +$74.7K +516 New
Citigroup
88
Citigroup
New York
$85K -$289 -2 -0.4%
MWNA
89
Marshall Wace North America
New York
$79K +$63.1K +436 New
CG
90
Caprock Group
Idaho
$72K
BNP Paribas Financial Markets
91
BNP Paribas Financial Markets
France
$70.7K +$49.5K +342 +684%
HighTower Advisors
92
HighTower Advisors
Illinois
$70K -$6.22K -43 -10%
Arrowstreet Capital
93
Arrowstreet Capital
Massachusetts
$63K +$50.6K +350 New
USAA
94
United Services Automobile Association
Texas
$61K
Legal & General Group
95
Legal & General Group
United Kingdom
$58K +$5.35K +37 +13%
MAM
96
Meeder Asset Management
Ohio
$34K +$19.4K +134 +216%
AG
97
Advisor Group
Arizona
$31K
Federated Hermes
98
Federated Hermes
Pennsylvania
$31K +$9.26K +64 +60%
AIP
99
Ameritas Investment Partners
Nebraska
$27K
US Bancorp
100
US Bancorp
Minnesota
$26K

SRGA Hedge Fund Activity: Q1 2019 in Review

113 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q1 2019, worth a combined $264M — up 60% from $165M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SRGA positions and 18 closed out — a net gain of 4 holders — while 31 added to existing stakes and 35 trimmed.

The largest buyer was Millrace Asset Group, opening a new position worth an estimated $1.74M. The largest seller was Krensavage Asset Management, cutting an estimated $2.28M.

  • 113 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q1 2019, up from 109 in Q4 2018.
  • Funds reported $264M of Surgalign Holdings, Inc. Common Stock stock for Q1 2019, up 60% quarter-over-quarter.
  • 22 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q1 2019 and 18 closed out, a net change of +4 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q1 2019 was Millrace Asset Group, an estimated $1.74M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q1 2019 was Krensavage Asset Management, an estimated $2.28M sold.

Based on aggregated 13F filings for Q1 2019.